Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration

Anne Sieben1,2,3,4, Tim Van Langenhove2,3, Yannick Vermeiren1,5

  • 1Institute Born-Bunge, Neuropathology and Laboratory of Neurochemistry and Behavior, University of Antwerp, Antwerp, Belgium.

Insights

Hippocampal sclerosis (HS) is strongly linked to TDP-43 proteinopathy in the hippocampus, particularly in frontotemporal dementia. Vascular changes also significantly correlate with HS, suggesting complex underlying pathology.

Area of Science:

  • Neuropathology
  • Neurodegenerative Diseases
  • Vascular Neurology

Background:

  • Hippocampal sclerosis (HS) is a common finding associated with aging, TDP-43 proteinopathy, and cerebrovascular issues.
  • Early-onset frontotemporal dementia (FTD) presents complex neuropathological features.
  • Understanding the interplay of pathologies in FTD is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate the relationship between HS and TDP-43 proteinopathy in early-onset FTD.
  • To identify additional factors associated with HS in this patient cohort.
  • To explore potential pathophysiological mechanisms linking TDP-43, cerebrovascular disease, and HS.

Main Methods:

  • Analysis of neuropathological data from an autopsy cohort of early-onset FTD patients.
  • Examination of relationships between HS, TDP-43 proteinopathy (hippocampal and frontotemporal), Alzheimer disease, cerebrovascular changes, and age.
  • Introduction of quantitative neuronal cell counting in CA1 for objective HS assessment.

Main Results:

  • A strong association was confirmed between HS and hippocampal TDP-43.
  • A weaker association was observed between HS and frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP).
  • HS was present in all FTLD-TDP type D cases, 50% of type A, and 6% of type B.
  • Significant associations were found between HS and vascular changes.

Conclusions:

  • TDP-43 proteinopathy, especially in the hippocampus, is strongly linked to HS in early-onset FTD.
  • Cerebrovascular changes are also significantly associated with HS.
  • Further research into the pathophysiological mechanisms connecting TDP-43, vascular disease, and HS is warranted.

Related Concept Videos

Role of Hippocampus in Memory01:19

Role of Hippocampus in Memory

The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
788
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
285
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K